Galderma Group Ltd header image

Galderma Group Ltd

GALD

Equity

ISIN CH1335392721 / Valor 133539272

SIX Swiss Exchange (2026-04-08)

CHF 157.40-2.30%

Galderma Group Ltd
UMushroom community rating:

4.33 3 votes No rating yet

NegativeNeutralPositive

About company

Galderma Group Ltd is a leading company in the dermatology sector, focusing exclusively on this field for over 40 years. The company specializes in developing, manufacturing, and marketing a wide range of dermatological treatments and solutions. Galderma's product portfolio includes therapeutic dermatology products, dermatological skincare, and injectable aesthetic treatments, catering to a diverse range of skin health needs. With a global presence, the company operates research and development centers and manufacturing facilities strategically located around the world. Galderma is dedicated to advancing the field of dermatology through continuous innovation and science-based solutions, aiming to enhance the quality of life for patients with various skin conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

95.3%1Y

%3Y

%5Y

Performance

33.4%1Y

31.0%3Y

31.0%5Y

Volatility

45488 M

Market cap (USD)

477,892

Daily traded volume (Shares)

100.6 / 98.35

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.33

3 votes

Performance:

4.00

Innovation:

4.00

Society:

3.00

Nature:

2.67

Laura Bischofberger

Switzerland, 12 Jun 2024

New kid on the block, lets see where they go after they IPO.

Hein Sweerts de Landas

Switzerland, 12 Jun 2024

It's the trend, personal beautification. Online: photoshop, real world: Galderma!

Lea Katunaric

Switzerland, 12 Jun 2024

Was never too keen on this type of procedures.

EQUITIES OF THE SAME SECTOR

ImmunityBio Inc

ImmunityBio Inc Valor: 110468647

Annual Return

-50%0%+50%

Risk level

110

-3.11%USD 6.86

Schrodinger Inc

Schrodinger Inc Valor: 51947209

Annual Return

-50%0%+50%

Risk level

110

-1.13%USD 11.39

Illumina Inc

Illumina Inc Valor: 1111080

Annual Return

-50%0%+50%

Risk level

110

-1.02%USD 126.44

Idorsia Ltd

Idorsia Ltd Valor: 36346343

Annual Return

-50%0%+50%

Risk level

110

-3.10%CHF 3.41

Ypsomed Holding AG

Ypsomed Holding AG Valor: 1939699

Annual Return

-50%0%+50%

Risk level

110

-3.04%CHF 271.00

Medartis Holding AG

Medartis Holding AG Valor: 38620023

Annual Return

-50%0%+50%

Risk level

110

-4.90%CHF 77.60

Xlife Sciences Ltd.

Xlife Sciences Ltd. Valor: 46192960

Annual Return

-50%0%+50%

Risk level

110

8.63%CHF 21.40

UCB SA

UCB SA Valor: 986410

Annual Return

-50%0%+50%

Risk level

110

-0.42%EUR 263.40

BridgeBio Pharma Inc

BridgeBio Pharma Inc Valor: 48204826

Annual Return

-50%0%+50%

Risk level

110

-0.48%USD 71.93

Ambu A/S

Ambu A/S Valor: 39639588

Annual Return

-50%0%+50%

Risk level

110

-6.59%DKK 64.50

SIX

FactSet

Clearbit

Logos provided by Clearbit